SCHEMBL2769680

SCHEMBL2769680

CN(C)c1cccc2onc(NC(=S)NCc3ccccc3)c12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.44
MAOA P21397 1/20 0.44
HPGD P15428 3/20 0.43
LMNA P02545 2/20 0.43
PLA2G1B P04054 1/20 0.43
ATG4B Q9Y4P1 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
KDM4E B2RXH2 1/20 0.42
HTT P42858 1/20 0.42
ALOX12 P18054 5/20 0.42
ALDH1A1 P00352 3/20 0.42
MAPT P10636 2/20 0.42
PKM P14618 1/20 0.42
POLB P06746 4/20 0.41
KMT2A Q03164 2/20 0.41
RAB9A P51151 2/20 0.41
GAA P10253 2/20 0.41
MEN1 O00255 1/20 0.41
THRB P10828 1/20 0.41
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2769328 0.83 ALDH1A1 (0.40) HPGDLMNASMN1; SMN2KDM4EHTT
SCHEMBL2773293 0.82 HPGD (0.51) MAOBMAOAHPGDLMNAPLA2G1B
SCHEMBL2769999 0.79 MAOB (0.54) MAOBMAOAHPGDLMNAPLA2G1B
SCHEMBL2767863 0.77 RAB9A (0.49) SMN1; SMN2KDM4EHTTALDH1A1MAPT
SCHEMBL2770798 0.76 ALDH1A1 (0.43) HPGDSMN1; SMN2KDM4EHTTALDH1A1
SCHEMBL2768888 0.76 ALDH1A1 (0.36) LMNAKDM4EHTTALOX12ALDH1A1
SCHEMBL2768385 0.76 ABL1 (0.42) HPGDLMNASMN1; SMN2KDM4EALOX12
SCHEMBL2769351 0.76 KDM4E (0.48) HPGDLMNASMN1; SMN2KDM4EHTT
SCHEMBL2770206 0.75 GAA (0.51) MAOBMAOAALDH1A1MAPTKMT2A
SCHEMBL2768567 0.74 IDO1 (0.42) MAOBMAOALMNAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1881967-B1 SUBSTITUTED BENZO(D)ISOXAZOL-3-YL AMINE COMPOUNDS AS ANALGESICS GRUENENTHAL GMBH (DE) 2010-04-28 EP claimed
US-20080176915-A1 Substituted Benzo[d]isoxazol-3-yl Amine Compounds as Analgesics GRUENENTHAL GMBH (DE) 2008-07-24 US claimed
US-7696238-B2 Substituted benzo[d]isoxazol-3-yl amine compounds as analgesics GRUENENTHAL GMBH (DE) 2010-04-13 US disclosed
US-20080176915-A1 Substituted Benzo[d]isoxazol-3-yl Amine Compounds as Analgesics GRUENENTHAL GMBH (DE) 2008-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080176915-A1 Substituted Benzo[d]isoxazol-3-yl Amine Compounds as Analgesics KCNQ1, KCNQ2, KCNQ3 MAOB 1172/4885MAOA 1116/4885HPGD 2090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.